CLINICAL_TRIALS
trial_result
· 2014-07-29
Clinical Trial Update: Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017) [Phase 2]
Summary
Phase 2 trial update assessing the safety of vorapaxar in Japanese subjects with cerebral infarction has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Cerebral Infarction | Phase 2 | Status: COMPLETED | Results posted: 2014-07-29